| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Snyder David S serves as a Chief Financial Officer at XCUR and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $89K at current prices.
The biggest single holding is COYA (~$63K) as Chief Financial Officer. Net of sales, the recent Form 4 record there shows accumulation of 8,800 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2024 | COYA Coya Therapeutics, Inc. | Chief Financial Officer | Buy | 1,800 | $7.19 | $12,934.44 | +25.7% | -2.9% | -13.8% | |
| Jan 3, 2023 | COYA Coya Therapeutics, Inc. | Chief Financial Officer | Buy | 7,000 | $0.00 | - | New | -12.9% | +48.2% | |
| Mar 12, 2020 | XCUR Exicure, Inc. | Chief Financial Officer | Buy | 18,248 | $1.40 | $25,591.00 | New | - | - |